NO970610L - Sammensetning for selektiv frigjöring av en aktiv ingrediens - Google Patents
Sammensetning for selektiv frigjöring av en aktiv ingrediensInfo
- Publication number
- NO970610L NO970610L NO970610A NO970610A NO970610L NO 970610 L NO970610 L NO 970610L NO 970610 A NO970610 A NO 970610A NO 970610 A NO970610 A NO 970610A NO 970610 L NO970610 L NO 970610L
- Authority
- NO
- Norway
- Prior art keywords
- composition
- water
- active ingredient
- selective release
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Den foreliggende oppfinnelse beskriver en sammensetning som omfatter følgende rekkefolge; (a) en kjerne av materiale som sveller i vann, (b) et elastisk vannuoppiøselig, vannpermeabelt lag, (c) et lag som inneholder en eller flere aktive ingredienser; og (d) et lag av et materiale som blir vannpermeabelt i et forutbestemt vandig medium, som er i stand til å ødelegges ved ekspansjon av kjernen. Anvendelse av nevnte sammensetning som et legemiddel er også beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9409963A FR2723536A1 (fr) | 1994-08-11 | 1994-08-11 | Composition permettant une liberation selective d'un principe actif |
PCT/FR1995/001079 WO1996004893A1 (fr) | 1994-08-11 | 1995-08-11 | Composition permettant une liberation selective d'un principe actif |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970610D0 NO970610D0 (no) | 1997-02-10 |
NO970610L true NO970610L (no) | 1997-03-21 |
Family
ID=9466272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970610A NO970610L (no) | 1994-08-11 | 1997-02-10 | Sammensetning for selektiv frigjöring av en aktiv ingrediens |
Country Status (14)
Country | Link |
---|---|
US (1) | US5824341A (no) |
EP (1) | EP0774960A1 (no) |
JP (1) | JPH10504300A (no) |
KR (1) | KR970704428A (no) |
AU (1) | AU698240B2 (no) |
CA (1) | CA2197234A1 (no) |
CZ (1) | CZ41297A3 (no) |
FI (1) | FI970530A (no) |
FR (1) | FR2723536A1 (no) |
HU (1) | HUT77387A (no) |
NO (1) | NO970610L (no) |
NZ (1) | NZ290848A (no) |
PL (1) | PL318586A1 (no) |
WO (1) | WO1996004893A1 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6511477B2 (en) * | 1997-03-13 | 2003-01-28 | Biocardia, Inc. | Method of drug delivery to interstitial regions of the myocardium |
US20010055613A1 (en) | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US20020131908A1 (en) * | 2000-01-13 | 2002-09-19 | George Benda | Selective release apparatus for fluids |
AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
US20030118647A1 (en) * | 2001-12-04 | 2003-06-26 | Pawan Seth | Extended release tablet of metformin |
US6913768B2 (en) * | 2002-09-24 | 2005-07-05 | Shire Laboratories, Inc. | Sustained release delivery of amphetamine salts |
US20040086567A1 (en) * | 2002-10-30 | 2004-05-06 | Pawan Seth | Bioequivalent composition of itraconazole and a hydrophilic polymer |
US20040162320A1 (en) * | 2003-02-14 | 2004-08-19 | Pawan Seth | Solid composition containing nisoldipine a mixture of polyethylene oxides and an antioxidant |
US20040249364A1 (en) * | 2003-06-03 | 2004-12-09 | Ilya Kaploun | Device and method for dispensing medication to tissue lining a body cavity |
US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US8110226B2 (en) * | 2007-07-20 | 2012-02-07 | Mylan Pharmaceuticals Inc. | Drug formulations having inert sealed cores |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
CA2769760A1 (en) * | 2009-07-31 | 2011-02-03 | Ranbaxy Laboratories Limited | Multi-layered, multiple unit pharmaceutical compositions |
BR112014007753B1 (pt) * | 2011-09-30 | 2021-07-06 | Astellas Pharma Inc. | composição farmacêutica granular, formulação e método para produção |
KR101384055B1 (ko) * | 2012-02-02 | 2014-04-14 | 한국원자력연구원 | 버스트형 지연 방출 제어 조성물 및 이의 제조방법 |
US20190083628A1 (en) * | 2016-02-23 | 2019-03-21 | Nipro Corporation | Pharmaceutical composition particles and orally disintegrating preparation including the same |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
DE3629994A1 (de) * | 1986-09-03 | 1988-03-17 | Weissenbacher Ernst Rainer Pro | Vorrichtung zur medikamentenapplikation in koerperhoehlen bzw. auf koerperoberflaechen |
JPH01501719A (ja) * | 1986-12-09 | 1989-06-15 | スカイ パーク アクチーボラグ | 車両移動装置 |
IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
US5178868A (en) * | 1988-10-26 | 1993-01-12 | Kabi Pharmacia Aktiebolaq | Dosage form |
US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
US5178866A (en) * | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
IE61651B1 (en) * | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
NZ286242A (en) * | 1991-03-26 | 1997-11-24 | Csl Ltd | Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient |
JP2892858B2 (ja) * | 1991-05-15 | 1999-05-17 | 田辺製薬株式会社 | 放出制御製剤およびその製造法 |
US5656296A (en) * | 1992-04-29 | 1997-08-12 | Warner-Lambert Company | Dual control sustained release drug delivery systems and methods for preparing same |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US5358502A (en) * | 1993-02-25 | 1994-10-25 | Pfizer Inc | PH-triggered osmotic bursting delivery devices |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
US5536507A (en) * | 1994-06-24 | 1996-07-16 | Bristol-Myers Squibb Company | Colonic drug delivery system |
US5736159A (en) * | 1995-04-28 | 1998-04-07 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
-
1994
- 1994-08-11 FR FR9409963A patent/FR2723536A1/fr active Pending
-
1995
- 1995-08-11 EP EP95927782A patent/EP0774960A1/fr not_active Ceased
- 1995-08-11 CA CA002197234A patent/CA2197234A1/fr not_active Abandoned
- 1995-08-11 KR KR1019970700903A patent/KR970704428A/ko not_active Application Discontinuation
- 1995-08-11 WO PCT/FR1995/001079 patent/WO1996004893A1/fr not_active Application Discontinuation
- 1995-08-11 US US08/776,797 patent/US5824341A/en not_active Expired - Fee Related
- 1995-08-11 NZ NZ290848A patent/NZ290848A/en unknown
- 1995-08-11 AU AU31699/95A patent/AU698240B2/en not_active Ceased
- 1995-08-11 CZ CZ97412A patent/CZ41297A3/cs unknown
- 1995-08-11 HU HU9700399A patent/HUT77387A/hu unknown
- 1995-08-11 PL PL95318586A patent/PL318586A1/xx unknown
- 1995-08-11 JP JP8507074A patent/JPH10504300A/ja active Pending
-
1997
- 1997-02-07 FI FI970530A patent/FI970530A/fi unknown
- 1997-02-10 NO NO970610A patent/NO970610L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ41297A3 (cs) | 1998-05-13 |
PL318586A1 (en) | 1997-06-23 |
NZ290848A (en) | 1998-03-25 |
NO970610D0 (no) | 1997-02-10 |
KR970704428A (ko) | 1997-09-06 |
FR2723536A1 (fr) | 1996-02-16 |
CA2197234A1 (fr) | 1996-02-22 |
EP0774960A1 (fr) | 1997-05-28 |
FI970530A0 (fi) | 1997-02-07 |
JPH10504300A (ja) | 1998-04-28 |
AU3169995A (en) | 1996-03-07 |
WO1996004893A1 (fr) | 1996-02-22 |
HUT77387A (hu) | 1998-04-28 |
AU698240B2 (en) | 1998-10-29 |
US5824341A (en) | 1998-10-20 |
FI970530A (fi) | 1997-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970610L (no) | Sammensetning for selektiv frigjöring av en aktiv ingrediens | |
NO974335D0 (no) | Laktam-holdige hydroksaminsyrederivater, deres fremstilling og deres anvendelse som inhibitorer for matriksmetallprotease | |
NO993003L (no) | Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter | |
DK1076657T3 (da) | Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling | |
DK0779807T3 (da) | Fremgangsmåde til fremstilling af en kappetablet med spids kerne | |
DK1398A (da) | Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse | |
PT98571A (pt) | Dispositivos para a libertacao controlada que utilizam membranas polimerizadas interfacialmente e de processos para a sua preparacao | |
DK0622408T3 (da) | Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler | |
NO982802D0 (no) | Nye 5-amino-3-cyano-4-etylsulfinyl-1-fenyl-pyrazol-forbindelser og deres anvendelse som pesticider | |
ES533580A0 (es) | Un metodo para preaparar una composicion farmaceutica para aplicacion topica que contiene n-(2 hidroxietil)-pirrolidona. | |
DK0771788T3 (da) | Substituerede sulfonimidamider, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnostikum og | |
BR9811099A (pt) | Inibidores de urocinase | |
NO992408D0 (no) | FremgangsmÕte for lavavfalls fremstilling av skiveformige formlegemer inneholdende aktive ingredienser, og transdermale terapeutiske systemer inneholdende samme | |
NO984080D0 (no) | Nye arylglycinamid-derivater, fremgangsmÕte for fremstilling derav og blandinger som inneholder disse forbindelser | |
DK0839149T3 (da) | Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem | |
ES2196620T3 (es) | Formulacion de liberacion prolongada que contiene venlafaxina. | |
NO980178L (no) | Cyklo-oksygenase-inhibitor og amidin-derivatsalter, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater | |
DK0727416T3 (da) | Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som | |
NO985807L (no) | Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament | |
DK0943030T3 (da) | Fremgangsmåde til reduktion af svovl- og kypefarvestoffer | |
NO961677D0 (no) | Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
DK0806949T3 (da) | Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf | |
NO992859D0 (no) | Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter | |
ATE215941T1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DK0810205T3 (da) | Substituerede 1-naphthoylguanidiner, fremgangsmåde til deres fremstiling, deres anvendelse som lægemiddel eller diagnostisk middel samt lægemiddel indeholdende dem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |